Literature DB >> 16584159

Porous polystyrene beads as carriers for self-emulsifying system containing loratadine.

Pradeep Patil1, Anant Paradkar.   

Abstract

The aim of this study was to formulate a self-emulsifying system (SES) containing a lipophilic drug, loratadine, and to explore the potential of preformed porous polystyrene beads (PPB) to act as carriers for such SES. Isotropic SES was formulated, which comprised Captex 200 (63% wt/wt), Cremophore EL (16% wt/wt), Capmul MCM (16% wt/wt), and loratadine (5% wt/wt). SES was evaluated for droplet size, drug content, and in vitro drug release. SES was loaded into preformed and characterized PPB using solvent evaporation method. SES-loaded PPB were evaluated using scanning electron microscopy (SEM) for density, specific surface area (S(BET)), loading efficiency, drug content, and in vitro drug release. After SES loading, specific surface area reduced drastically, indicating filling of PPB micropores with SES. Loading efficiency was least for small size (SS) and comparable for medium size (MS) and large size (LS) PPB fractions. In vitro drug release was rapid in case of SS beads due to the presence of SES near to surface. LS fraction showed inadequate drug release owing to presence of deeper micropores that resisted outward diffusion of entrapped SES. Leaching of SES from micropores was the rate-limiting step for drug release. Geometrical features such as bead size and pore architecture of PPB were found to govern the loading efficiency and in vitro drug release from SES-loaded PPB.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16584159      PMCID: PMC2750735          DOI: 10.1208/pt070128

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  12 in total

1.  Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients.

Authors:  S Nazzal; M Nutan; A Palamakula; R Shah; A A Zaghloul; M A Khan
Journal:  Int J Pharm       Date:  2002-06-20       Impact factor: 5.875

2.  Powdered solution technology: principles and mechanism.

Authors:  S S Spireas; C I Jarowski; B D Rohera
Journal:  Pharm Res       Date:  1992-10       Impact factor: 4.200

3.  Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound.

Authors:  S A Charman; W N Charman; M C Rogge; T D Wilson; F J Dutko; C W Pouton
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

4.  Dissolution rates of corticoid solutions dispersed on silicas.

Authors:  C C Liao; C I Jarowski
Journal:  J Pharm Sci       Date:  1984-03       Impact factor: 3.534

5.  Effect of formulation variables on preparation and evaluation of gelled self-emulsifying drug delivery system (SEDDS) of ketoprofen.

Authors:  Pradeep Patil; Prasad Joshi; Anant Paradkar
Journal:  AAPS PharmSciTech       Date:  2004-07-22       Impact factor: 3.246

Review 6.  Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs.

Authors:  R Neslihan Gursoy; Simon Benita
Journal:  Biomed Pharmacother       Date:  2004-04       Impact factor: 6.529

7.  Fabrication of porous hollow silica nanoparticles and their applications in drug release control.

Authors:  Zhu-Zhu Li; Li-Xiong Wen; Lei Shao; Jian-Feng Chen
Journal:  J Control Release       Date:  2004-08-11       Impact factor: 9.776

8.  Classification of loratadine based on the biopharmaceutics drug classification concept and possible in vitro-in vivo correlation.

Authors:  M Zahirul I Khan; Dragica Rausl; Ruzica Zanoski; Snjezana Zidar; Jasna Horvat Mikulcić; Lara Krizmanić; Maja Eskinja; Boris Mildner; Zdravka Knezević
Journal:  Biol Pharm Bull       Date:  2004-10       Impact factor: 2.233

9.  In vitro release evaluation of hydrocortisone liquisolid tablets.

Authors:  S Spireas; S Sadu; R Grover
Journal:  J Pharm Sci       Date:  1998-07       Impact factor: 3.534

10.  The use of solid self-emulsifying systems in the delivery of diclofenac.

Authors:  A A Attama; I T Nzekwe; P O Nnamani; M U Adikwu; C O Onugu
Journal:  Int J Pharm       Date:  2003-08-27       Impact factor: 5.875

View more
  8 in total

1.  Development of solid self-emulsifying drug delivery system (SEDDS) I: use of poloxamer 188 as both solidifying and emulsifying agent for lipids.

Authors:  Ankita V Shah; Abu T M Serajuddin
Journal:  Pharm Res       Date:  2012-02-28       Impact factor: 4.200

2.  Development of Solid SEDDS, IV: Effect of Adsorbed Lipid and Surfactant on Tableting Properties and Surface Structures of Different Silicates.

Authors:  Suhas G Gumaste; Sara A Pawlak; Damon M Dalrymple; Charles J Nider; Louis D Trombetta; Abu T M Serajuddin
Journal:  Pharm Res       Date:  2013-06-26       Impact factor: 4.200

3.  Development of Solid SEDDS, V: Compaction and Drug Release Properties of Tablets Prepared by Adsorbing Lipid-Based Formulations onto Neusilin® US2.

Authors:  Suhas G Gumaste; Damon M Dalrymple; Abu T M Serajuddin
Journal:  Pharm Res       Date:  2013-06-25       Impact factor: 4.200

4.  Porous carriers for controlled/modulated drug delivery.

Authors:  G Ahuja; K Pathak
Journal:  Indian J Pharm Sci       Date:  2009-11       Impact factor: 0.975

5.  Porous magnesium aluminometasilicate tablets as carrier of a cyclosporine self-emulsifying formulation.

Authors:  Camilla Sander; Per Holm
Journal:  AAPS PharmSciTech       Date:  2009-11-20       Impact factor: 3.246

6.  Development of self-microemulsifying drug delivery system and solid-self-microemulsifying drug delivery system of telmisartan.

Authors:  Parul Jaiswal; Geeta Aggarwal; Sasidharan Leelakumari Harikumar; Kashmir Singh
Journal:  Int J Pharm Investig       Date:  2014-10

7.  Enhanced transdermal permeability of piroxicam through novel nanoemulgel formulation.

Authors:  Bhavna Dhawan; Geeta Aggarwal; Sl Harikumar
Journal:  Int J Pharm Investig       Date:  2014-04

8.  Development, stability and in vitro delivery profile of new loratadine-loaded nanoparticles.

Authors:  Jesus Rafael Rodriguez Amado; Ariadna Lafourcade Prada; Jonatas Lobato Duarte; Hady Keita; Heitor Rivero da Silva; Adriana Maciel Ferreira; Edgar Hernandez Sosa; Jose Carlos Tavares Carvalho
Journal:  Saudi Pharm J       Date:  2017-07-19       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.